000 01247 a2200337 4500
005 20250516042458.0
264 0 _c20111011
008 201110s 0 0 eng d
022 _a1747-4094
024 7 _a10.1586/ehm.11.30
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSison, Edward Allan R
245 0 0 _aThe bone marrow microenvironment and leukemia: biology and therapeutic targeting.
_h[electronic resource]
260 _bExpert review of hematology
_cJun 2011
300 _a271-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntineoplastic Agents
_xchemistry
650 0 4 _aBone Marrow
_xmetabolism
650 0 4 _aChemokine CXCL12
_xmetabolism
650 0 4 _aClinical Trials as Topic
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aHematopoiesis
650 0 4 _aHumans
650 0 4 _aLeukemia
_xtherapy
650 0 4 _aPeptides
_xchemistry
650 0 4 _aReceptors, CXCR4
_xantagonists & inhibitors
700 1 _aBrown, Patrick
773 0 _tExpert review of hematology
_gvol. 4
_gno. 3
_gp. 271-83
856 4 0 _uhttps://doi.org/10.1586/ehm.11.30
_zAvailable from publisher's website
999 _c20923648
_d20923648